14 January 2011
Smiths Group confirms that it has received an approach for Smiths Medical which it has rejected.
The value offered was £2.45 billion in cash, as a best and final offer, subject inter alia, to extensive due diligence and completion of financing.
The Board has carefully considered this approach with its advisers and has concluded that it would not be in the interests of shareholders to pursue discussions on the basis of an indication at this price level.
In reaching this conclusion, the Board has taken into account the quality and highly cash generative nature of Smiths Medical, both standalone and in the context of the Group as a whole.
Related articles
![Interconnect Connector](/media/3hnni12p/interconnect-connector.jpg?width=431&height=214&format=webp&quality=100&v=1dad7688743f780)
Smiths Interconnect launches new technology to improve connectivity in mission critical applications
Read our latest company news as Smiths Interconnect launches new connector technology
Find out more![Ariane 6](/media/obfincds/ariane-6.jpg?width=431&height=214&format=webp&quality=100&v=1dad295a87941d0)
Smiths Group supports launch of Ariane 6 space rocket
Read our latest company news as Smiths Group supports the launch of the Ariane 6 space rocket
Find out more![Smiths Detection HI SCAN 6040 Ctix](/media/pksfrrfr/smiths-detection-hi-scan_6040_ctix.jpg?width=431&height=214&format=webp&quality=100&v=1dacdfb885247b0)
Smiths Detection Selected by Zurich Airport to Trial Advances CT X-Ray Scanners
Read our latest company news as Smiths Detection is selected by by Zurich Airport to Trial Advances CT X-Ray Scanners.
Find out more